MedPath

Cefadroxil

Cefadroxil

Approved
Approval ID

f6ddd84a-4a44-7035-e053-6294a90a6606

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 2, 2023

Manufacturers
FDA

Direct_Rx

DUNS: 079254320

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefadroxil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72189-445
Application NumberANDA065392
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefadroxil
Product Specifications
Route of AdministrationORAL
Effective DateJune 2, 2023
FDA Product Classification

INGREDIENTS (13)

D&C RED NO. 28Inactive
Code: 767IP0Y5NH
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POTASSIUM HYDROXIDEInactive
Code: WZH3C48M4T
Classification: IACT
CEFADROXILActive
Quantity: 500 mg in 1 1
Code: 280111G160
Classification: ACTIM
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.